Volume 93, issue 11, Novembre 2006

Electronic Journal of Oncology

A phase II trial of miltefosine in patients with cutaneous T-cell lymphoma (p.10115-8)
Charles Dumontet, Luc Thomas, Frédéric Bérard, Jean François Gimonet, Bertrand Coiffier

Enhancing radiosensitivity of Hela cells by combining transfection of bcl-2 c-myc ASODNs (p.10119-25)
Rongrong Li, Yufeng Cheng, Chengjin Gao

Éditorial

Cellules souches et cancer : the last frontier ? (p.1083-4)
Christian-Jacques Larsen

Brèves

La protéine suppresseur de tumeur PML bloque la néoangiogenèse en réprimant mTor (p.1085-6)
Christian-Jacques Larsen
Open Access

Cancers bronchiques non à petites cellules : ERCC1, un biomarqueur thérapeutique en vue (p.1086)
Jean Bénard
Open Access

Dossier thématique

Neoadjuvant chemotherapy in non small cell lung cancer (p.1087-92)
Benjamin Besse, Stéphane Vignot, Thierry Le Chevalier

Neoadjuvant chemotherapy in sarcoma (p.1093-8)
Jean-Yves Blay, Sylvie Bonvalot, Jérôme Fayette, Eberhart Stockle, Isabelle Ray-Coquard, Jean-Marie Coindre, Florence Duffaud, Sophie Taieb, Marie-Pierre Sunyach, Dominique Ranchere, Pierre Meeus, Axel Le Cesne, Binh Nguyen Bui

Neoadjuvant hormonal treatment combined with external irradiation in the management of prostate cancer (p.1101-5)
Michel Bolla, Xavier Artignan, Philippe Fourneret, Danielle Brochon, François Ringeisen, Jean-Luc Descotes

Place of neoadjuvant treatments in oesophageal cancers care (p.1107-13)
Gilles Créhange, Fabrice Lorchel, Jean-François Bosset

Neoadjuvant treatment in osteosarcomas (p.1115-20)
Chantal Kalifa, Laurence Brugières, Marie-Cécile Le Deley

Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer (p.1121-9)
Marie-Ange Mouret-Reynier, Catherine Abrial, Marianne Leheurteur, Xavier Durando, Isabelle Van Praagh, Pierre Gimbergues, Jean-Louis Achard, Jean-Pierre Ferrière, Hervé Cure, Philippe Chollet

Synthèse

The fluorescence: a « bright » concept for the study of the metastatic process (p.1131-8)
Sébastien Paris

Update on clinical activity of CCI779 (temsirolimus), mTOR inhibitor (p.1139-43)
Nicolas Mounier, Stéphane Vignot, Jean-Philippe Spano

Article original

How to measure research emerging from hospitals? The case of French comprehensive cancer centres (p.1144-51)
Julia Bonastre, Gérard de Pouvourville

Tribune libre

Request for a compassionate use of biotherapies in oncology (p.1152-4)
Dominique Hauteville